PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC

Clinical trial pipeline · Data from ClinicalTrials.gov

See which PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 3

NCT06635824

Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cel…

This is a multicenter, randomized, open-label, international, Phase 3 trial to evaluate the efficacy and safety of acasunlimab in combination with pembrolizumab…

United States191 participantsStarted 2024-11-25

Treatment: Acasunlimab, Pembrolizumab